DanCann Pharma A/S nominates Tue Østergaard to the Board of Directors at the Company’s Annual General Meeting
COPENHAGEN, Denmark, 13 April 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the Company nominates Tue Østergaard to join the Board of Directors at the upcoming Annual General Meeting on April 27th, 2022.The board’s competencies will be further strengthened in the investor relations field with his documented results and his passion for Danish small and midcap companies. In 2020, Tue Østergaard chose to leave the Norwegian investment bank ABG Sundal Collier. After nine years as investment manager